Growth Metrics

Novartis Ag (NVS) Enterprise Value Growth (5y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 27.86%
Sep 30, 2025 135.43%
Jun 30, 2025 -2.44%
Mar 31, 2025 15.30%
Dec 31, 2024 27.91%
Sep 30, 2024 -39.29%
Jun 30, 2024 9.74%
Dec 31, 2023 1.25%
Sep 30, 2023 -58.33%
Jun 30, 2023 -6.31%
Mar 31, 2023 -19.73%
Dec 31, 2022 -14.72%
Sep 30, 2022 -15.44%
Jun 30, 2022 13.60%
Mar 31, 2022 -21.59%
Dec 31, 2021 -31.15%
Sep 30, 2021 -0.38%
Jun 30, 2021 -15.48%
Mar 31, 2021 -14.87%
Dec 31, 2020 -19.18%
Sep 30, 2020 86.46%
Jun 30, 2020 -7,737.37%
Mar 31, 2020 -1,533.14%
Dec 31, 2019 50.02%
Sep 30, 2019 1,484.89%
Jun 30, 2019 -5,253.58%
Mar 31, 2019 -2,645.26%
Dec 31, 2018 -4,099.40%
Sep 30, 2018 1,337.42%
Jun 30, 2018 -3,552.35%
Mar 31, 2018 659.13%
Sep 30, 2017 1,644.98%
Jun 30, 2017 -3,567.20%
Mar 31, 2017 2,090.69%
Dec 31, 2016 -3,664.52%
Sep 30, 2016 1,649.54%
Jun 30, 2016 8,336.09%
Mar 31, 2016 8,125.20%
Dec 31, 2015 -2,974.32%
Sep 30, 2015 -6,891.71%
Jun 30, 2015 -36.90%
Mar 31, 2015 35.30%
Dec 31, 2014 -161.80%
Sep 30, 2014 15.50%
Jun 30, 2014 27.23%
Mar 31, 2014 15.74%